
Euro Tech Holdings Company Limited
CLWTNASDAQIndustrials● Active
$1.48
+$0.25(+20.30%)
Market Cap$10966743
P/E Ratio—
52W High$1.63
52W Low$0.99
Euro Tech Holdings Company Limited(CLWT)· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · CLWT · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.16M | $0.73M | $1.83M | $0.37M | $0.99M |
| Depreciation & Amort. | $0.16M | $0.15M | $0.01M | $0.03M | $0.04M |
| Stock-Based Comp. | $0.00M | $0.01M | $0.05M | $0.04M | $0.06M |
| Change in Working Capital | ($1.43M) | $0.14M | $0.13M | $0.22M | $1.23M |
| Net Cash from Operations | ($1.09M) | $0.78M | ($0.08M) | $0.46M | $2.20M |
| Investing Activities | |||||
| Capital Expenditure | ($0.01M) | ($0.01M) | ($0.01M) | ($0.01M) | ($0.00M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | ($1.20M) |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.01M) | $0.30M | $0.32M | $0.23M | $0.36M |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.32M) | ($0.01M) | ($0.01M) | $0.00M | $0.00M |
| Dividends Paid | $0.00M | ($0.62M) | $0.00M | ($0.46M) | ($1.03M) |
| Debt Issued / Repaid | $0.00M | ($0.15M) | ($0.07M) | ($0.15M) | $0.01M |
| Net Cash from Financing | ($0.32M) | ($0.78M) | ($0.08M) | ($0.62M) | ($1.02M) |
| Free Cash Flow | |||||
| Free Cash Flow | ($1.10M) | $0.78M | ($0.09M) | $0.45M | $2.20M |
| FCF Margin %(computed) | -8.30% | 5.04% | -0.47% | 3.04% | 10.27% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M
深入了解Euro Tech Holdings Company Limited
关于Euro Tech Holdings Company Limited(CLWT)现金流量表
Euro Tech Holdings Company Limited 2025财年经营活动现金流($0.00B),自由现金流($0.00B)(FCF利润率-8.30%),资本支出($0.00B)。
常见问题
CLWT · 4 问Euro Tech Holdings Company Limited 2025财年自由现金流($0.00B),同比down241.9%。
CLWT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10